Agonox, Inc.
Portland, OR
- UEI
- YNKLZNLCCE85
- CAGE
- 6Q1F9
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 4805 NE Glisan St, Portland, OR 97213, USA
- Website
- agonox.com
- Founded
- 2012
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Humanization of a mouse anti-OX40 monoclonal antibody to treat cancer | National Institutes of Health | $293,706 |
Quick answers
Is Agonox, Inc. registered in SAM.gov?
Yes. Agonox, Inc.'s SAM.gov registration is active through May 26, 2027.
What is Agonox, Inc.'s most recent federal award?
Agonox, Inc.'s most recent federal grant award is Humanization of a mouse anti-OX40 monoclonal antibody to treat cancer (R43CA159797), from National Institutes of Health, on June 15, 2012.
On GovTribe
See Agonox, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors